MedTrace Logo

Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic AF

NCT00958165 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2016-08-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the safety and effectiveness of the endoscopic ablation system - adaptive contact (EAS-AC) in treated paroxysmal atrial fibrillation (PAF) with pulmonary vein isolation (PVI).

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

DEVICE

CardioFocus EAS-AC

PVI for PAF

Sponsors & Collaborators

  • CardioFocus

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2012-03-31
Completion
2012-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00958165 on ClinicalTrials.gov